The Enterprise Value as of November 2024 (TTM) for TScan Therapeutics, Inc. (TCRX) is 115.90M

According to TScan Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 115.90M. This represents a change of -75.85% compared to the average of 479.81M of the last 4 quarters.

TScan Therapeutics, Inc. (TCRX) Historical Enterprise Value (quarterly & annually)

How has TCRX Enterprise Value performed in the past?

The mean historical Enterprise Value of TScan Therapeutics, Inc. over the last ten years is 151.29M. The current 115.90M Enterprise Value has changed 7.56% with respect to the historical average. Over the past ten years (40 quarters), TCRX's Enterprise Value was at its highest in in the March 2024 quarter at 711.21M. The Enterprise Value was at its lowest in in the March 2022 quarter at -68063002.40.

TScan Therapeutics, Inc. (TCRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TScan Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TScan Therapeutics, Inc. (TCRX) Average Enterprise Value

How has TCRX Enterprise Value performed in the past?

The current Enterprise Value of TScan Therapeutics, Inc. (TCRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TScan Therapeutics, Inc. (TCRX) Enterprise Value vs. Peers

How is TCRX’s Enterprise Value compared to its peers?

TScan Therapeutics, Inc.’s Enterprise Value is less than VectivBio Holding AG (848.58M), less than Icosavax, Inc. (713.87M), less than Apellis Pharmaceuticals, Inc. (3.64B), greater than iTeos Therapeutics, Inc. (76.18M), less than Day One Biopharmaceuticals, Inc. (1.08B), less than Acumen Pharmaceuticals, Inc. (137.49M), greater than X4 Pharmaceuticals, Inc. (20.13M), less than Inozyme Pharma, Inc. (310.02M), greater than Cognition Therapeutics, Inc. (-8637153.00), greater than TFF Pharmaceuticals, Inc. (2.31M), greater than Cue Biopharma, Inc. (71.55M), greater than Dermata Therapeutics, Inc. (-3114171.00), less than ProQR Therapeutics N.V. (279.26M), less than Annexon, Inc. (644.70M), less than Arrowhead Pharmaceuticals, Inc. (2.90B), less than Terns Pharmaceuticals, Inc. (503.60M),

Build a custom stock screener for TScan Therapeutics, Inc. (TCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TScan Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TScan Therapeutics, Inc. (TCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TScan Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.